Inspire Medical Systems, Inc. Cash and Restricted Cash
Inspire Medical Systems, Inc. (INSP) had Cash and Restricted Cash of $127.76 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $127.76M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $98.93M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $104.81M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $112.84M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $127.76M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $98.93M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $104.81M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $112.84M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $106.93M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $53.88M 10-Q · filed 2026-05-04 |
| 2024-12-31 | $150.15M 10-Q · filed 2026-08-03 |
| 2024-09-30 | $147.51M 10-Q · filed 2025-11-03 |
| 2024-06-30 | $188.03M 10-Q · filed 2025-08-04 |
| 2024-03-31 | $175.42M 10-Q · filed 2025-05-05 |
| 2023-12-31 | $185.54M 10-K · filed 2026-02-13 |
| 2023-09-30 | $329.90M 10-Q · filed 2024-11-04 |
| 2023-06-30 | $467.05M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $442.13M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $441.59M 10-K · filed 2026-02-13 |
| 2022-09-30 | $417.81M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $186.57M 10-Q · filed 2023-08-01 |
| 2022-03-31 | $203.29M 10-Q · filed 2023-05-02 |
| 2021-12-31 | $214.47M 10-K · filed 2025-02-10 |
| 2021-09-30 | $210.20M 10-Q · filed 2022-11-01 |
| 2021-06-30 | $176.54M 10-Q · filed 2022-08-02 |
| 2021-03-31 | $182.35M 10-Q · filed 2022-05-03 |
| 2020-12-31 | $190.52M 10-K · filed 2024-02-09 |
| 2020-09-30 | $178.71M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $211.24M 10-Q · filed 2021-08-03 |
| 2020-03-31 | $76.12M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $22.86M 10-K · filed 2023-02-10 |
| 2019-09-30 | $48.04M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $51.27M 10-Q · filed 2020-08-04 |
| 2019-03-31 | $101.94M 10-Q · filed 2020-05-05 |
| 2018-12-31 | $97.29M 10-K · filed 2022-02-15 |
| 2018-09-30 | $26.31M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $121.85M 10-Q · filed 2019-08-06 |
| 2017-12-31 | $8.96M 10-K · filed 2021-02-24 |
| 2016-12-31 | $6.68M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |